These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 7892763)

  • 1. Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRI.
    Landes-Chateau C; Levraut M; Cohen M; Sicard M; Papeix C; Cotton F; Balcerac A; Themelin A; Mondot L; Lebrun-Frenay C; ;
    Rev Neurol (Paris); 2023 Dec; 179(10):1103-1110. PubMed ID: 37730469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.
    Manschot SM; Biessels GJ; de Valk H; Algra A; Rutten GE; van der Grond J; Kappelle LJ;
    Diabetologia; 2007 Nov; 50(11):2388-97. PubMed ID: 17764005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter lesions and cognitive performance: the role of cognitively complex leisure activity.
    Saczynski JS; Jonsdottir MK; Sigurdsson S; Eiriksdottir G; Jonsson PV; Garcia ME; Kjartansson O; van Buchem MA; Gudnason V; Launer LJ
    J Gerontol A Biol Sci Med Sci; 2008 Aug; 63(8):848-54. PubMed ID: 18772473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical ischemic vascular disease and cognition: A systematic review.
    Alves GS; Alves CEO; Lanna ME; Moreira DM; Engelhardt E; Laks J
    Dement Neuropsychol; 2008; 2(2):82-90. PubMed ID: 29213548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review.
    Wu Y; Wei Q; Lin J; Shang H; Ou R
    Front Cell Neurosci; 2024; 18():1369332. PubMed ID: 38638300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
    Zhou Y; Yu F; Duong TQ;
    J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral and muscle MRI abnormalities in myotonic dystrophy.
    Franc DT; Muetzel RL; Robinson PR; Rodriguez CP; Dalton JC; Naughton CE; Mueller BA; Wozniak JR; Lim KO; Day JW
    Neuromuscul Disord; 2012 Jun; 22(6):483-91. PubMed ID: 22290140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.
    Wozniak JR; Mueller BA; Ward EE; Lim KO; Day JW
    Neuromuscul Disord; 2011 Feb; 21(2):89-96. PubMed ID: 21169018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients.
    Romeo V; Pegoraro E; Squarzanti F; Sorarù G; Ferrati C; Ermani M; Zucchetta P; Chierichetti F; Angelini C
    Neurol Sci; 2010 Dec; 31(6):757-63. PubMed ID: 20842397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain involvement in myotonic dystrophies: neuroimaging and neuropsychological comparative study in DM1 and DM2.
    Romeo V; Pegoraro E; Ferrati C; Squarzanti F; Sorarù G; Palmieri A; Zucchetta P; Antunovic L; Bonifazi E; Novelli G; Trevisan CP; Ermani M; Manara R; Angelini C
    J Neurol; 2010 Aug; 257(8):1246-55. PubMed ID: 20221771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroencephalographic coherence analysis in multiple sclerosis: correlation with clinical, neuropsychological, and MRI findings.
    Leocani L; Locatelli T; Martinelli V; Rovaris M; Falautano M; Filippi M; Magnani G; Comi G
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):192-8. PubMed ID: 10896692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis.
    Rovaris M; Filippi M; Minicucci L; Iannucci G; Santuccio G; Possa F; Comi G
    AJNR Am J Neuroradiol; 2000 Feb; 21(2):402-8. PubMed ID: 10696031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperintensive intramedullary lesions in psychiatric patients. Spatial distribution and psychopathologic symptoms].
    Becker T; Schmidtke A; Stöber G; Franzek E; Teichmann E; Hofmann E
    Nervenarzt; 1994 Mar; 65(3):191-7. PubMed ID: 8177360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
    Tiemann L; Penner IK; Haupts M; Schlegel U; Calabrese P
    Mult Scler; 2009 Oct; 15(10):1164-74. PubMed ID: 19667010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
    J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognition and white matter lesions.
    Desmond DW
    Cerebrovasc Dis; 2002; 13 Suppl 2():53-7. PubMed ID: 11901244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of white matter lesions (WML) to Parkinson's disease cognitive impairment symptoms: A critical review of the literature.
    Veselý B; Rektor I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S166-70. PubMed ID: 26391185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter lesions and cognitive deficits: relevance of lesion pattern?
    Damian MS; Schilling G; Bachmann G; Simon C; Stöppler S; Dorndorf W
    Acta Neurol Scand; 1994 Dec; 90(6):430-6. PubMed ID: 7892763
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.